| Docetaxel studied in …STUDIED_INderived200 of 1,729show all (up to 200) |
|---|
| → studied in | NCT05007106Phase 2 · completed MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005) · 1,729 trials list this drug (321 active) | — | — | Esophageal Neoplasm,Gastric Neoplasm,Gallbladder Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05901428Phase 3 · recruiting TCb vs EC-T in High Risk ER+/HER2- Breast Cancer · 1,729 trials list this drug (321 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06780098Phase 2 · recruiting Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I) · 1,729 trials list this drug (321 active) | — | — | Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03390504Phase 3 · active not recruiting A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene Aberrations · 1,729 trials list this drug (321 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05132075Phase 3 · active not recruiting Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer · 1,729 trials list this drug (321 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05818683Phase 1 · recruiting A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer · 1,729 trials list this drug (321 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06545955Phase 3 · recruiting A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer · 1,729 trials list this drug (321 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07225946Phase 3 · recruiting A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer · 1,729 trials list this drug (321 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07419295Phase 3 · recruiting A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031) · 1,729 trials list this drug (321 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00295893Phase 2 · active not recruiting Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer · 1,729 trials list this drug (321 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04340882Phase 2 · active not recruiting Phase 2 DoceRamPem for Patients With Metastatic or Recurrent NSCLC Who Progressed on Platinum-Doublet and PD-1/PD-L1 Blockade · 1,729 trials list this drug (321 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06123338Phase 2 · recruiting A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer · 1,729 trials list this drug (321 active) | — | — | Malignant Esophageal Neoplasm,Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03367676Phase 2 · terminated 12 weekS Adjuvant dOcetaxel Plus trastuzumaB in Patients With Small, Node-negative, HER2-positive Breast cancER (SOBER) · 1,729 trials list this drug (321 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04400695Phase 3 · recruiting A Study of RC48-ADC for the Treatment of Locally Advanced or Metastatic Breast Cancer With Low Expression of HER2 · 1,729 trials list this drug (321 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04928846Phase 3 · recruiting A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) · 1,729 trials list this drug (321 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06524544Phase 3 · recruiting A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer · 1,729 trials list this drug (321 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07213674Phase 3 · recruiting A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer · 1,729 trials list this drug (321 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07415031Phase 2 · recruiting A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies · 1,729 trials list this drug (321 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01350817Phase 2 · completed Erlotinib and Docetaxel in Second Line of Treatment in Patients With Non Small Cell Lung Cancer · 1,729 trials list this drug (321 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07829900completed First-Line Dual Versus Single HER2-Targeted Therapy With Docetaxel for Advanced HER2-Positive Breast Cancer · 1,729 trials list this drug (321 active) | — | — | Malignant Breast Neoplasm,HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07831863Phase 3 · not yet recruiting A Study of 7MW3711 Compared With Docetaxel in Advanced Squamous NSCLC After Prior Chemoimmunotherapy · 1,729 trials list this drug (321 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04634877Phase 3 · active not recruiting Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053) · 1,729 trials list this drug (321 active) | — | — | Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05027633Phase 2 · recruiting Immunotherapy With Chemotherapy and Chemoradiation for Advanced Squamous Cancer of Nasal Cavity / Paranasal Sinuses (I-NAPA) · 1,729 trials list this drug (321 active) | — | — | Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06227065Phase 2 · not yet recruiting Precise Chemoresection in Low-grade NMIBC Using Drug Screens in Patient-derived Organoids · 1,729 trials list this drug (321 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07365995Phase 3 · recruiting A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer · 1,729 trials list this drug (321 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01658462Phase 2 · completed Phase II Study of Docetaxel +/- Nintedanib in Breast Cancer · 1,729 trials list this drug (321 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06340568Phase 3 · recruiting A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer · 1,729 trials list this drug (321 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06353386Phase 1/Phase 2 · recruiting Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A) · 1,729 trials list this drug (321 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06568094Phase 1/Phase 2 · recruiting A Study of HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced Prostate Cancer · 1,729 trials list this drug (321 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06629597Phase 3 · active not recruiting A Phase III Study of YL201 in Recurrent or Metastatic Nasopharyngeal Carcinoma (TAISHAN-301) · 1,729 trials list this drug (321 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06863272Phase 1/Phase 2 · recruiting A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02) · 1,729 trials list this drug (321 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06925737Phase 3 · recruiting A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001) · 1,729 trials list this drug (321 active) | — | — | Prostate Neoplasm,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06952504Phase 3 · recruiting A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29) · 1,729 trials list this drug (321 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07566052Phase 3 · recruiting A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation · 1,729 trials list this drug (321 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07824869Phase 2 · not yet recruiting A Phase II Study of HLX22 in Combination With Trastuzumab and Chemotherapy in HER2-Positive Locally Advanced or Metastatic Breast Cancer Patients · 1,729 trials list this drug (321 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04579224Phase 3 · active not recruiting Comparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer · 1,729 trials list this drug (321 active) | — | — | Urothelial Carcinoma,Bladder Urothelial Carcinoma,Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07821684Phase 3 · not yet recruiting A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan Compared to Standard of Care in Adult Participants Previously Treated, EGFR Wildtype, Locally Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer · 1,729 trials list this drug (321 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05538663Phase 3 · active not recruiting Intravesical BCG vs GEMDOCE in NMIBC · 1,729 trials list this drug (321 active) | — | — | Non-Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03070886Phase 2/Phase 3 · active not recruiting Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery · 1,729 trials list this drug (321 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03493425Phase 2 · active not recruiting Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery · 1,729 trials list this drug (321 active) | — | — | Sinonasal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04140526Phase 1/Phase 2 · active not recruiting Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC · 1,729 trials list this drug (321 active) | — | — | Solid Neoplasm,Malignant Breast Neoplasm,Melanoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04266249Phase 2 · active not recruiting CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy · 1,729 trials list this drug (321 active) | — | — | Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04310007Phase 2 · active not recruiting Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer · 1,729 trials list this drug (321 active) | — | — | Malignant Lung Neoplasm,Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06266299Phase 1 · recruiting A Study of KK2269 in Adult Participants With Solid Tumors · 1,729 trials list this drug (321 active) | — | — | Solid Neoplasm,Lung Non-Small Cell Carcinoma,Esophageal Adenocarcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04001829Phase 2 · active not recruiting Docetaxel or Paclitaxel in Reducing Chemotherapy-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer · 1,729 trials list this drug (321 active) | — | — | Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06635824Phase 3 · active not recruiting Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06) · 1,729 trials list this drug (321 active) | — | — | Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03906071Phase 3 · completed Phase 3 Study of Sitravatinib Plus Nivolumab vs Docetaxel in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer · 1,729 trials list this drug (321 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04577014Phase 1/Phase 2 · recruiting Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma · 1,729 trials list this drug (321 active) | — | — | Sarcoma,Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06764485Phase 3 · active not recruiting A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer · 1,729 trials list this drug (321 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02642042Phase 2 · active not recruiting Trametinib and Docetaxel in Treating Patients With Recurrent or Stage IV KRAS Mutation Positive Non-small Cell Lung Cancer · 1,729 trials list this drug (321 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07291037Phase 3 · recruiting Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations · 1,729 trials list this drug (321 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07805135Phase 3 · not yet recruiting A Study of HB1801 Versus Docetaxel (Taxotere®) in Patients With Advanced Breast Cancer · 1,729 trials list this drug (321 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03178552Phase 2/Phase 3 · active not recruiting A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC) · 1,729 trials list this drug (321 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04633252Phase 1/Phase 2 · recruiting A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer · 1,729 trials list this drug (321 active) | — | — | Prostate Neoplasm,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06989112Phase 3 · recruiting DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer · 1,729 trials list this drug (321 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07287150Phase 2 · recruiting A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer · 1,729 trials list this drug (321 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07723248Phase 3 · recruiting A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1) · 1,729 trials list this drug (321 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04276493Phase 1/Phase 2 · completed Anti-HER2 Bispecific Antibody Zanidatamab (ZW25) Activity in Combination With Chemotherapy With/Without Tislelizumab · 1,729 trials list this drug (321 active) | — | — | Malignant Breast Neoplasm,Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06632327Phase 3 · active not recruiting Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer · 1,729 trials list this drug (321 active) | — | — | Malignant Lung Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06931340Phase 3 · recruiting Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial · 1,729 trials list this drug (321 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm,Castration-Sensitive Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01810913Phase 2/Phase 3 · suspended Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer · 1,729 trials list this drug (321 active) | — | — | Laryngeal Squamous Cell Carcinoma,Hypopharyngeal Squamous Cell Carcinoma,Oropharyngeal Squamous Cell Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05054439Phase 2 · active not recruiting A Clinical Study of SI-B001 in Combination With Paclitaxel/Docetaxel in the Treatment of Recurrent and Metastatic HNSCC · 1,729 trials list this drug (321 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05378763Phase 3 · suspended A Study of Poziotinib in Previously Treated Participants With Locally Advanced or Metastatic NSCLC Harboring HER2 Exon 20 Mutations · 1,729 trials list this drug (321 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07797153Phase 3 · not yet recruiting JSKN033 Versus Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Cancer · 1,729 trials list this drug (321 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07797218Phase 3 · recruiting Neoadjuvant Pyrotinib-to-pertuzumab in HER2+ eBC · 1,729 trials list this drug (321 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03505320Phase 2 · active not recruiting A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer · 1,729 trials list this drug (321 active) | — | — | Gastric Neoplasm,Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05126719Phase 2 · active not recruiting A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent Metastatic Nasopharyngeal Carcinoma · 1,729 trials list this drug (321 active) | — | — | Nasopharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05942001Phase 1 · recruiting Study of HRS-5041 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) · 1,729 trials list this drug (321 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06940180Phase 2 · recruiting Toripalimab With Chemotherapy for Sinus Cancer · 1,729 trials list this drug (321 active) | — | — | Malignant Head and Neck Neoplasm,Malignant Sinonasal Neoplasm,Paranasal Sinus Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07070440Phase 1/Phase 2 · recruiting DZD6008 Combination Therapy in Patients With Locally Advanced or Metastatic NSCLC With EGFR Mutation (TIAN-SHAN7) · 1,729 trials list this drug (321 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07768189Phase 3 · not yet recruiting A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma · 1,729 trials list this drug (321 active) | — | — | Oropharyngeal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00588770Phase 3 · active not recruiting Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma · 1,729 trials list this drug (321 active) | — | — | Malignant Major Salivary Gland Neoplasm,Salivary Gland Carcinoma,Laryngeal Squamous Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00781612Phase 2 · active not recruiting A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies · 1,729 trials list this drug (321 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06682780Phase 1/Phase 2 · recruiting A Phase I/II Study of LM-2417 in Subjects With Advanced Solid Tumours · 1,729 trials list this drug (321 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06783647Phase 2 · recruiting A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)] · 1,729 trials list this drug (321 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06881784Phase 3 · recruiting Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301) · 1,729 trials list this drug (321 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07590934Phase 1/Phase 2 · recruiting Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer · 1,729 trials list this drug (321 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07698535Phase 2 · recruiting Measuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO Trial · 1,729 trials list this drug (321 active) | — | — | Malignant Prostate Neoplasm,Castration-Resistant Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00334815Phase 2 · active not recruiting Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery · 1,729 trials list this drug (321 active) | — | — | Lung Large Cell Carcinoma,Lung Squamous Cell Carcinoma,Lung Adenocarcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01652469Phase 3 · completed Testing of Drugs Erlotinib and Docetaxel in Lung Cancer Patients Classified Regarding Their Outlook Using VeriStrat®. · 1,729 trials list this drug (321 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03442556Phase 2 · terminated Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency · 1,729 trials list this drug (321 active) | — | — | Prostate Adenocarcinoma,Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04025879Phase 3 · active not recruiting A Study of Neoadjuvant Chemotherapy Plus Nivolumab Versus Neoadjuvant Chemotherapy Plus Placebo, Followed by Surgical Removal and Adjuvant Treatment With Nivolumab or Placebo for Participants With Surgically Removable Early Stage Non-small Cell Lung Cancer · 1,729 trials list this drug (321 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04656652Phase 3 · active not recruiting Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01) · 1,729 trials list this drug (321 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06891833Phase 2/Phase 3 · recruiting A Study of BL-M07D1 With or Without Pertuzumab Versus Docetaxel + Carboplatin + Trastuzumab + Pertuzumab in Neoadjuvant Therapy for HER2-Positive Breast Cancer · 1,729 trials list this drug (321 active) | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07102381Phase 2 · recruiting A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer · 1,729 trials list this drug (321 active) | — | — | Malignant Breast Neoplasm,HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07316686Phase 1 · recruiting Phase I Study of Docetaxel and 177-Lutetium-PSMA-I&T in First-Line Treatment for Patients With Metastatic Castration-Resistant Prostate Adenocarcinoma · 1,729 trials list this drug (321 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03801876Phase 3 · active not recruiting Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer · 1,729 trials list this drug (321 active) | — | — | Thoracic Esophagus Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06441890Phase 2 · recruiting BRE-10: Biomarker Optimization of Neoadjuvant Therapy in Breast Cancer · 1,729 trials list this drug (321 active) | — | — | Malignant Breast Neoplasm,HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06223568Phase 2 · active not recruiting Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer · 1,729 trials list this drug (321 active) | — | — | Head and Neck Squamous Cell Carcinoma,Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06741644Phase 1/Phase 2 · recruiting A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors · 1,729 trials list this drug (321 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06864533recruiting Adjuvant Chemotherapy for High Malignant Prostate Cancer · 1,729 trials list this drug (321 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06929286Phase 3 · recruiting A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC) · 1,729 trials list this drug (321 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03740165Phase 3 · completed Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036) · 1,729 trials list this drug (321 active) | — | — | Peritoneal Neoplasm,Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07246863Phase 2 · recruiting Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC · 1,729 trials list this drug (321 active) | — | — | Adult Solid Neoplasm,Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04895709Phase 1/Phase 2 · recruiting A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors · 1,729 trials list this drug (321 active) | — | — | Melanoma,Ovarian Neoplasm,Head and Neck Squamous Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05408845Phase 2 · recruiting Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers · 1,729 trials list this drug (321 active) | — | — | Malignant Major Salivary Gland Neoplasm,Salivary Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04812366Phase 2 · recruiting Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer · 1,729 trials list this drug (321 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05083481Phase 1 · terminated A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors · 1,729 trials list this drug (321 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06074588Phase 3 · active not recruiting Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004) · 1,729 trials list this drug (321 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04522336Phase 1 · completed Pembrolizumab and Chemoradiotherapy for the Treatment of Unresectable Gastroesophageal Cancer · 1,729 trials list this drug (321 active) | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05671510Phase 3 · active not recruiting ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors · 1,729 trials list this drug (321 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06120075Phase 1 · active not recruiting A Study of AB801 Monotherapy and Combination Therapy in Participants With Advanced Malignancies · 1,729 trials list this drug (321 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04126070Phase 2 · active not recruiting Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors · 1,729 trials list this drug (321 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04354662Phase 2 · completed Toripalimab Combined With FLOT Neoadjuvant Chemotherapy in Patients With Resectable Gastric Cancer · 1,729 trials list this drug (321 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04685135Phase 3 · active not recruiting Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation · 1,729 trials list this drug (321 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06551324Phase 3 · active not recruiting A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1). · 1,729 trials list this drug (321 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07668752Phase 3 · recruiting A Study to Evaluate GFH375 Versus Docetaxel in Participants With Non-Small Cell Lung Cancer With KRAS G12D Mutation · 1,729 trials list this drug (321 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05999994Phase 2 · recruiting A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer · 1,729 trials list this drug (321 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01547741Phase 3 · completed Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer · 1,729 trials list this drug (321 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06439693Phase 2 · recruiting The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer · 1,729 trials list this drug (321 active) | — | — | Malignant Breast Neoplasm,HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05176483Phase 1 · recruiting Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors · 1,729 trials list this drug (321 active) | — | — | Solid Neoplasm,Head and Neck Squamous Cell Carcinoma,Hepatocellular Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05676203Phase 3 · active not recruiting A Trial Comparing Docetaxel 75 mg/m2 (3w) Versus Docetaxel 50 mg/m2 (2w) in Combination With Darolutamide + ADT in mHSPC Patients · 1,729 trials list this drug (321 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07747740Phase 2 · recruiting Sequential Gemcitabine Plus Docetaxel Versus Gemcitabine Plus Mitomycin C for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer · 1,729 trials list this drug (321 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06644781Phase 3 · recruiting A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01) · 1,729 trials list this drug (321 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07017673Phase 2 · recruiting Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer · 1,729 trials list this drug (321 active) | — | — | Early Stage Triple-Negative Breast Carcinoma,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07743632Phase 2 · not yet recruiting Neoadjuvant Angiogenesis-Targeting Bispecific Chemoimmunotherapy for TNBC · 1,729 trials list this drug (321 active) | — | — | Malignant Breast Neoplasm,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03517969Phase 2 · active not recruiting M6620 and Carboplatin With or Without Docetaxel in Treating Patients With Metastatic Castration-Resistant Prostate Cancer · 1,729 trials list this drug (321 active) | — | — | Malignant Prostate Neoplasm,Prostate Carcinoma,Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05063552Phase 2/Phase 3 · active not recruiting Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers · 1,729 trials list this drug (321 active) | — | — | Malignant Lip and Oral Cavity Neoplasm,Malignant Sinonasal Neoplasm,Head and Neck Squamous Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05382559Phase 1 · recruiting A Study of ASP3082 in Adults With Advanced Solid Tumors · 1,729 trials list this drug (321 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06532032Phase 1/Phase 2 · completed A Study of Combination Therapy With Amivantamab and Docetaxel in Participants With Metastatic Non-small Cell Lung Cancer · 1,729 trials list this drug (321 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07196774Phase 3 · active not recruiting A Trial of SHR-A1811 Compared to Other Antitumor Therapies as Neoadjuvant Treatments in Early-stage or Locally Advanced HER2-positive Breast Cancer · 1,729 trials list this drug (321 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07669415Phase 2 · recruiting A Study of LM-168 Combined With Other Anti-tumor Treatments in Participants With Advanced Solid Tumors · 1,729 trials list this drug (321 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02486718Phase 3 · active not recruiting Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010] · 1,729 trials list this drug (321 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06445400Phase 2 · active not recruiting A Study of BL-M07D1, BL-M07D1+Pertuzumab and BL-M07D1+Pertuzumab+Docetaxel in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer · 1,729 trials list this drug (321 active) | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06914687Phase 2 · active not recruiting Efficacy of Tirellizumab Combined With Oral, Intravenous and Abdominal Chemotherapy in Peritoneal Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma · 1,729 trials list this drug (321 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07730151Phase 2 · not yet recruiting Efficacy and Safety of Darolutamide Combined With Docetaxel and ADT as Neoadjuvant Therapy for Locally Advanced Prostate Cancer. · 1,729 trials list this drug (321 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05616624Phase 1/Phase 2 · terminated ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung Cancers · 1,729 trials list this drug (321 active) | — | — | Lung Non-Small Cell Carcinoma,Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06745908Phase 3 · recruiting Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In · 1,729 trials list this drug (321 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03456843Phase 2 · active not recruiting Therapeutic Effect of Cytoreductive Radical Prostatectomy in Men With Newly Diagnosed Metastatic Prostate Cancer · 1,729 trials list this drug (321 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04615013Phase 1 · recruiting NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer · 1,729 trials list this drug (321 active) | — | — | Gastroesophageal Junction Adenocarcinoma,Cervical Esophagus Adenocarcinoma,Thoracic Esophagus Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05714553Phase 1/Phase 2 · terminated NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours · 1,729 trials list this drug (321 active) | — | — | Malignant Neoplasm,Solid Neoplasm,Melanoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05719558Phase 1 · recruiting A Study of ASP1002 in Adults for Treatment of Solid Tumors · 1,729 trials list this drug (321 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06012435Phase 3 · active not recruiting A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer · 1,729 trials list this drug (321 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06304974Phase 3 · active not recruiting A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma(PANKU-Esophagus01) · 1,729 trials list this drug (321 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06472245Phase 3 · recruiting Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor · 1,729 trials list this drug (321 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06724042Phase 1 · not yet recruiting Study of ISM5939 in Patients With Advanced and/or Metastatic Solid Tumors · 1,729 trials list this drug (321 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00076310Phase 2 · completed OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer · 1,729 trials list this drug (321 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04303780Phase 3 · completed Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200). · 1,729 trials list this drug (321 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05142189Phase 1 · recruiting Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer · 1,729 trials list this drug (321 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01933932Phase 3 · active not recruiting Assess Efficacy & Safety of Selumetinib in Combination With Docetaxel in Patients Receiving 2nd Line Treatment for v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Positive NSCLC · 1,729 trials list this drug (321 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04722523Phase 1 · recruiting A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer · 1,729 trials list this drug (321 active) | — | — | Malignant Head and Neck Neoplasm,Malignant Neck Neoplasm,Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06520345Phase 3 · recruiting The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global) · 1,729 trials list this drug (321 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00707473Phase 2 · terminated Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer · 1,729 trials list this drug (321 active) | — | — | Sinonasal Carcinoma,Sinonasal Poorly Differentiated Carcinoma,Sinonasal Squamous Cell Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05006794Phase 1 · terminated Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GS-9716 as Monotherapy and in Combination With Anticancer Therapies in Adults With Solid Malignancies · 1,729 trials list this drug (321 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05296798Phase 3 · active not recruiting A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer) · 1,729 trials list this drug (321 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07487896Phase 3 · recruiting A Study of YL201 Versus Investigator's Choice of Chemotherapy in Participants With Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma After Failure of First-Line Therapy · 1,729 trials list this drug (321 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03317158Phase 1/Phase 2 · active not recruiting Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder · 1,729 trials list this drug (321 active) | — | — | Urothelial Carcinoma,Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06592924Phase 3 · recruiting Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response · 1,729 trials list this drug (321 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07214987Phase 2 · recruiting PDT For Induction Therapy For Head And Neck Cancer · 1,729 trials list this drug (321 active) | — | — | Malignant Head and Neck Neoplasm,Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07386938Phase 3 · active not recruiting A Study of the Efficacy, Safety and Pharmacokinetics of RPH-051 and Perjeta® in Combination With Trastuzumab and Docetaxel as the 1st Line Therapy in Patients With HER2-positive Breast Cancer · 1,729 trials list this drug (321 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07435311Phase 1 · completed A Phase I Comparative Study of Pharmacokinetics, Safety, and Efficacy of RPH-002 and Erbitux® in Unresectable Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma · 1,729 trials list this drug (321 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07435324Phase 3 · completed A Comparative Study of Efficacy and Safety of RPH-002 and Erbitux® in Unresectable Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma · 1,729 trials list this drug (321 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07699757Phase 1 · not yet recruiting HSK41959 With Standard Therapy in Solid Tumors With MTAP Deletion · 1,729 trials list this drug (321 active) | — | — | Solid Neoplasm,Lung Non-Small Cell Carcinoma,Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04840264Phase 2 · recruiting Docetaxel, Oxaliplatin and 5-FU for Gastric Cancer With Inoperable Malignant Bowel Obstruction · 1,729 trials list this drug (321 active) | — | — | Gastric Adenocarcinoma,Gastroesophageal Junction Adenocarcinoma,Peritoneal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05024734Phase 2 · active not recruiting Guiding Instillation in Non Muscle-invasive Bladder Cancer Based on Drug Screens in Patient Derived Organoids · 1,729 trials list this drug (321 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05450692Phase 3 · active not recruiting A Phase III Study of Ceralasertib Plus Durvalumab Versus Docetaxel in Patients With Non Small Cell Lung Cancer (NSCLC) Whose Disease Progressed On or After Prior Anti PD (L)1 Therapy And Platinum Based Chemotherapy · 1,729 trials list this drug (321 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06346392Phase 3 · active not recruiting AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2 · 1,729 trials list this drug (321 active) | — | — | Gastric Neoplasm,Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07518147Phase 3 · recruiting A Study Comparing BL-M05D1 With the Investigator's Choice of Treatment Regimen in Patients With Claudin (CLDN)18.2-Positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GC/GEJC) Who Have Received Prior First-Line Treatment · 1,729 trials list this drug (321 active) | — | — | Malignant Gastric Neoplasm,Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06747338Phase 3 · active not recruiting A Phase III Study of KN026 in Combination With HB1801 ± Carboplatin as Neoadjuvant Treatment for Early or Locally Advanced HER2-Positive Breast Cancer · 1,729 trials list this drug (321 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07344779active not recruiting A Study to Learn How Men With Advanced Prostate Cancer Respond to Treatment With Darolutamide and Hormone Therapy, With or Without Chemotherapy, in Real-world Medical Practice · 1,729 trials list this drug (321 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04037527Phase 1 · terminated Gemcitabine and Docetaxel With Radiation in Adults With Soft Tissue Sarcoma of the Extremities · 1,729 trials list this drug (321 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04655976Phase 2/Phase 3 · active not recruiting Efficacy Comparison of Cobolimab + Dostarlimab + Docetaxel to Dostarlimab + Docetaxel to Docetaxel Alone in Participants With Advanced Non-small Cell Lung Cancer Who Have Progressed on Prior Anti-PD-(L)1 Therapy and Chemotherapy · 1,729 trials list this drug (321 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05836584Phase 2 · active not recruiting Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer · 1,729 trials list this drug (321 active) | — | — | Gastric Adenocarcinoma,Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01012297Phase 3 · terminated Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma · 1,729 trials list this drug (321 active) | — | — | Uterine Corpus Sarcoma,Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00324805Phase 3 · completed Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery · 1,729 trials list this drug (321 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05726370Phase 2 · recruiting Preoperative Pembrolizumab and Chemotherapy in Resectable, Recurrent HNSCC · 1,729 trials list this drug (321 active) | — | — | Head and Neck Neoplasm,Malignant Head and Neck Neoplasm,Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07662018recruiting Prospective Observational Study of Outcomes After Gemcitabine, Docetaxel, Melphalan, and Carboplatin With Autologous Stem Cell Transplantation in Pediatric Relapsed/Refractory Germ Cell Tumors · 1,729 trials list this drug (321 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07660094Phase 3 · recruiting Aglatimagene Besadenovec + Prodrug and Pembrolizumab vs Docetaxel for Stage IV Non-Squamous NSCLC Progressing on Pembrolizumab (AURORA) · 1,729 trials list this drug (321 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00253318Phase 1 · terminated RAD001 Plus Docetaxel in Patients With Metastatic Breast Cancer · 1,729 trials list this drug (321 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06498648Phase 1/Phase 2 · recruiting Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma · 1,729 trials list this drug (321 active) | — | — | Soft Tissue Sarcoma,Dedifferentiated Liposarcoma,Leiomyosarcoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07333066Phase 3 · recruiting Phase III Randomized International Open Label Clinical Trial of Treatment Intensification With Docetaxel Plus Apalutamide in Patients With Metastatic Hormone-sensitive Prostate Cancer Who Did Not Achieve a Deep PSA Response After Initial Treatment With Apalutamide: REINFORCE Trial. · 1,729 trials list this drug (321 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07645326Phase 2 · not yet recruiting RISK-ADAPT Protocol in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) · 1,729 trials list this drug (321 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07416994Phase 3 · recruiting Pivotal Study to Evaluate YL202 Versus Docetaxel in Patients With Locally Advanced or Metastatic EGFR Sensitive Mutation Non-Squamous Non-Small Cell Lung Cancer · 1,729 trials list this drug (321 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01154920Phase 2 · active not recruiting Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma · 1,729 trials list this drug (321 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05076760Phase 1 · recruiting MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors · 1,729 trials list this drug (321 active) | — | — | Malignant Neoplasm,Solid Neoplasm,Malignant Head and Neck Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05235542Phase 1/Phase 2 · completed A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors · 1,729 trials list this drug (321 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04879368Phase 3 · completed RegoNivo vs Standard of Care Chemotherapy in AGOC · 1,729 trials list this drug (321 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05215067Phase 2 · completed A Phase II Trial of AK104 in Advanced Non-Small Cell Lung Cancer · 1,729 trials list this drug (321 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03137771Phase 2 · active not recruiting Maintenance Chemotherapy With or Without Local Consolidative Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer · 1,729 trials list this drug (321 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07632690Phase 3 · not yet recruiting QLC5508 in Participants With Metastatic Prostate Cancer · 1,729 trials list this drug (321 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06463665Phase 2 · recruiting Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer · 1,729 trials list this drug (321 active) | — | — | Lung Non-Small Cell Carcinoma,Lung Non-Small Cell Squamous Carcinoma,Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07518173Phase 3 · recruiting A Study of BL-M07D1 Combined With Pertuzumab Versus Docetaxel Plus Trastuzumab and Pertuzumab in Patients With First-line HER2-positive Recurrent or Metastatic Breast Cancer · 1,729 trials list this drug (321 active) | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05062980Phase 1 · terminated Quaratusugene Ozeplasmid (Reqorsa) in Combination With Pembrolizumab in Previously Treated Non-Small Lung Cancer · 1,729 trials list this drug (321 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04527991Phase 3 · completed Study of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread · 1,729 trials list this drug (321 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05633667Phase 2 · active not recruiting Study of Novel Treatment Combinations in Patients With Lung Cancer · 1,729 trials list this drug (321 active) | — | — | Lung Neoplasm,Malignant Lung Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05676931Phase 2 · active not recruiting Study With Various Immunotherapy Treatments in Participants With Lung Cancer · 1,729 trials list this drug (321 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07459751Phase 2/Phase 3 · recruiting A Global Phase II/III Clinical Study to Evaluate the Efficacy and Safety of HLX43 Monotherapy or HLX43 in Combination With HLX07 Versus Docetaxel in Advanced or Metastatic Squamous Non-Small Cell Lung Cancer · 1,729 trials list this drug (321 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07618624Phase 2 · enrolling by invitation BRIDGE Study: Neoadjuvant Finotonlimab, Cetuximab, and Docetaxel in Resectable Recurrent HNSCC After Immunotherapy Progression · 1,729 trials list this drug (321 active) | — | — | Malignant Head and Neck Neoplasm,Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03199885Phase 3 · terminated Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer · 1,729 trials list this drug (321 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm,Breast Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05094336Phase 1/Phase 2 · active not recruiting A Study of Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101) · 1,729 trials list this drug (321 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00600496Phase 1 · completed A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886) · 1,729 trials list this drug (321 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm,Melanoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05910827Phase 1/Phase 2 · recruiting A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers · 1,729 trials list this drug (321 active) | — | — | Squamous Cell Carcinoma,Cervical Squamous Cell Carcinoma,Esophageal Squamous Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07609251Phase 2 · not yet recruiting A Clinical Study of SCTB41 Combined With Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer（Phase II Study Ongoing） · 1,729 trials list this drug (321 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05800587Phase 2 · recruiting Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer · 1,729 trials list this drug (321 active) | — | — | Malignant Lung Neoplasm,Lung Non-Small Cell Carcinoma,Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05848011Phase 2 · completed A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer · 1,729 trials list this drug (321 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02504489Phase 3 · completed Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC · 1,729 trials list this drug (321 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04329065Phase 2 · recruiting Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer · 1,729 trials list this drug (321 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05431270Phase 1/Phase 2 · recruiting Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study) · 1,729 trials list this drug (321 active) | — | — | Lung Non-Small Cell Carcinoma,Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04154956Phase 3 · terminated SAR408701 Versus Docetaxel in Previously Treated, Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small-cell Lung Cancer Patients · 1,729 trials list this drug (321 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05096663Phase 2/Phase 3 · active not recruiting Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) · 1,729 trials list this drug (321 active) | — | — | Malignant Lung Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |